Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar;45(2):147-152.
doi: 10.1111/ced.14095. Epub 2019 Nov 19.

Melanoma-associated retinopathy

S Elsheikh  1 , S P Gurney  1 , M A Burdon  1
Affiliations
Review

Melanoma-associated retinopathy

S Elsheikh et al. Clin Exp Dermatol. 2020 Mar.

Abstract

Melanoma-associated retinopathy (MAR) is a rare paraneoplastic autoimmune manifestation of cutaneous malignant melanoma. Patients classically present with acute onset night blindness, positive visual phenomena and visual field defects, and typically have significantly reduced quality of life as a result. Early recognition of MAR is of prognostic significance as it can precede the diagnosis of primary or metastatic malignant melanoma, and early treatment can lower the risk of irreversible immunological damage to the retinal cells with improved visual outcomes. The focus of our review article is therefore to raise awareness of MAR and present the latest evidence relating to the investigation and management of this condition.

PubMed Disclaimer

References

    1. Ladewig G, Reinhold U, Thirkill CE et al. Incidence of antiretinal antibodies in melanoma: screening of 77 serum samples from 51 patients with American Joint Committee on Cancer stage I-IV. Br J Dermatol 2005; 152: 931-8.
    1. Liu C-H, Wang N-K, Sun M-H. Melanoma-associated retinopathy. Taiwan J Ophthalmol 2014; 4: 184-8.
    1. Pfohler C, Preuss KD, Tilgen W et al. Mitofilin and titin as target antigens in melanoma-associated retinopathy. Int J Cancer 2007; 120: 788-95.
    1. Rahimy E, Sarraf D. Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and management. Surv Ophthalmol 2013; 58: 430-58.
    1. Haus AH, Palmowski AM, Pföhler C et al. Melanoma-associated retinopathy: screening for melanoma-associated retinopathy in patients with cutaneous malignant melanoma. Neuro Ophthalmol 2002; 27: 121-37.

MeSH terms